Top Stocks on the Move: Medi Swipe Inc., New Western Energy Corp., Titan
Pharmaceuticals Inc., and Advanced Cell Technology Inc.
NEW YORK, January 7, 2013
NEW YORK, January 7, 2013 /PRNewswire/ --
PremierEquityReports.com provides investors with quality research and analysis
on U.S. equities on the move and today issues a report on: Medi Swipe, Inc.
(OTCBB: MWIP), New Western Energy, Inc. (OTCBB: NWTR), Titan Pharmaceuticals,
Inc. (OTCBB: TTNP), and Advanced Cell Technology, Inc. (OTCBB: ACTC).
Medi Swipe, Inc. (OTCBB: MWIP) has recently announced a new corporate
headquarters in Birmingham, Michigan. The Company made the decision to move
from South Florida based on recent and favorable state legislation regarding
medical marijuana and dispensary laws. Medi Swipe, Inc. hit a new all-time
high of $0.035 on January 4, 2013. Medi Swipe, Inc. has gained nearly 135% so
far in the month of January.
Read the entire press release issued by Medi Swipe, Inc. (OTCBB: MWIP) here:
New Western Energy Corp. (OTCBB: NWTR) has recently completed the acquisition
of 8 property leases totaling 1,520 acres and 106 oil wells in Roger County,
Oklahoma, from Pioneer Oil Development LLC. New Western Energy intends to
provide the development funds necessary to bring in to production the existing
wells, as well as the drilling of additional wells upon completion of the work
overs. Within the acquired leases is 950 contiguous acres of which a full 640
acre section has open drilling opportunities of multiple proven oil and gas
President and CEO, Javan Khazali, stated,"We are continuing to execute on our
strategy of aggressively acquiring performing assets that are underdeveloped
and will drive our growth in production." New Western Energy hit a new
all-time high of $1.13 on January 3, 2013.
Read the entire press release issued by New Western Energy Corp. (OTCBB: NWTR)
Titan Pharmaceuticals, Inc. (OTCBB: TTNP) recently announced that the New Drug
Application (NDA) for Probuphine® has been accepted for review and granted
Priority Review designation by the U.S. Food and Drug Administration (FDA).
Probuphine® is a novel, sub dermal implant and the first long-acting product
designed to deliver six months of the drug buprenorphine hydrochloride
following a single treatment. Titan Pharmaceuticals submitted the NDA for the
maintenance treatment of opioid dependence in adult patients in October 2012
under Section 505(b)(2) of the Food, Drug and Cosmetic Act and referenced the
approved sublingual tablet formulations of buprenorphine.
Titan Pharmaceuticals, Inc. has gained nearly 31% so far in the month of
Read the entire press release issued by Titan Pharmaceuticals, Inc. (OTCBB:
Advanced Cell Technology, Inc. (OTCBB: ACTC) recently appeared in the
'Christmas and New Year Special' issue of New Scientist . Advanced Cell
Technology's iPS cell-driven human platelet program has been named as one of
the "10 Ideas That Will Shape the Year," by the magazine. New Scientist is
widely considered to be one of the most influential science and technology
news magazines in the world.
"Human iPS cells are a game-changer in medicine," said Robert Lanza, M.D.,
chief scientific officer of Advanced Cell Technology. "They offer the
possibility to generate a non-controversial, unlimited source of
patient-specific stem cells without embryo destruction…We hope to initiate the
first clinical trial using these promising cells in 2013."
Advanced Cell Technology, Inc. has gained nearly 44% so far in the month of
Read the entire press release issued by Advanced Cell Technology, Inc. (OTCBB:
Sign up to receive detailed reports and stock picks at
http://www.PremierEquityReports.com . For real-time trade updates, follow our
award winning hedge fund trader on Twitter @StockBrainiac. Premier Equity
Reports also offers a FREE text message alert service to ensure that you
receive all alerts. Simply text " reports " to 63566 .
Premier Equity Reports is the U.S. leader in equity reports, offering quality
reports to investors looking for the most undervalued companies in the market.
Premier Equity Reports provides its subscribers with timely information and
exclusive analysis on U.S. companies with substantial upside potential.
Premier Equity Reports is the #1 free financial newsletter in the industry.
Sign up now and see why thousands have joined already.
Disclosure: PremierEquityReports.com is not a registered investment advisor
and nothing contained in any materials should be construed as a recommendation
to buy or sell securities. Investors should always conduct their own due
diligence with any potential investment. Premier Equity Reports is a wholly
owned entity of Equities Awareness Group LLC. Equities Awareness Group LLC has
been compensated up to fifty thousand dollars for marketing awareness on New
Western Energy Corp. Please read our report and visit our website, for
complete risks and disclosures.
Contact Information: Equities Awareness Group LLCMichael Perinotti
email@example.com http://www.EquitiesAG.com +1-201-917-5934
Third Party Publishing Provider: FNNewswire, a FN Media Group, LLC Company.
Press spacebar to pause and continue. Press esc to stop.